SIXIS GROUP LIMITED
Company number 06518350 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: SIXIS GROUP LIMITED
1. Financial Health Score: B+
Explanation: The company has demonstrated a remarkable recovery from a prolonged period of insolvency (negative net assets from 2014-2020) to a position of positive and growing equity. Profitability is strong, cash reserves are healthy, and external debt is minimal. However, the going concern dependency on the director's financial support and significant related-party balances prevent a higher grade. This patient has made an extraordinary recovery, but still requires monitoring for underlying conditions.
2. Key Vital Signs
| Vital Sign | 2024 | 2023 | Interpretation |
|---|---|---|---|
| Net Assets | £566,042 | £386,557 | ✅ Healthy and growing – up 46.5% |
| Profit for Year | £179,485 | £200,260 | ✅ Strong profitability, though slightly declining |
| Cash Position | £89,645 | £38,995 | ✅ Robust liquidity – more than doubled |
| Current Ratio | 15.9x | 2.0x | ✅ Excellent short-term solvency |
| Net Current Assets | £211,513 | £152,355 | ✅ Strong working capital position |
| Total Debt | £14,000 | £22,000 | ✅ Minimal external borrowing |
| Shareholders' Funds | £566,042 | £386,557 | ✅ Positive equity restored |
Historical Context – The Recovery Story
The financial history reveals a dramatic turnaround:
| Year | Net Assets | Cash | Shareholders' Funds |
|---|---|---|---|
| 2014 | £-173,000* | £7,369 | N/A |
| 2015 | N/A | £6,718 | £-131,468 |
| 2016 | £-99,989 | £1,645 | £-99,990 |
| 2017 | £-98,126 | £3,852 | £-98,127 |
| 2018 | £-29,451 | £287 | £-29,452 |
| 2019 | £-43,549 | £6,937 | £-43,550 |
| 2020 | £-51,062 | £6,194 | £-51,063 |
| 2023 | £386,557 | £38,995 | £386,556 |
| 2024 | £566,042 | £89,645 | £566,042 |
*Estimated from total assets and total liabilities
This represents a swing of approximately £617,000 from the 2016 nadir to the 2024 position – a financial resurrection.
3. Diagnosis
Primary Condition: Recovered Insolvency with Dependency Risk
The patient has made a remarkable recovery from a chronic condition. For at least six consecutive years (2014-2020), the company was technically insolvent – liabilities exceeded assets, sometimes significantly. The turnaround to positive net assets of £566,042 represents a genuine financial transformation.
Symptoms Analysis
✅ Healthy Signs
-
Strong Profitability: £179,485 profit in 2024 (and £200,260 in 2023) demonstrates the business model is generating returns. This is the financial equivalent of a strong pulse – the company is generating lifeblood.
-
Excellent Liquidity: The current ratio of 15.9x means the company has nearly £16 of current assets for every £1 of current liabilities. This is extremely healthy – the patient has ample reserves to meet short-term obligations.
-
Growing Cash Reserves: Cash has increased from £287 (2018 – dangerously low) to £89,645. This is like a patient building up their immune system after a serious illness.
-
Minimal External Debt: Only £14,000 in bank loans remains, down from £22,000. The company is not over-leveraged and has been steadily deleveraging.
-
Investment in Subsidiaries: £359,208 in subsidiary investments (with £120,000 added in 2024) suggests strategic growth and confidence in the group structure.
⚠️ Concerning Symptoms
-
Going Concern Dependency: The accounts explicitly state the company "is dependent on financial support from the director in order to meet its liabilities as they fall due on a day to day basis." This is a significant red flag – like a patient who is healthy only while on medication. If the director withdraws support, the company's ability to continue is jeopardised.
-
Related-Party Balances: - Director owed the company £56,784 (down from £116,195) - A connected company owed £60,945 (up from £44,825) – interest-free and repayable on demand
These balances represent nearly 40% of current assets. The interest-free nature and repayable-on-demand terms suggest these may not be truly arm's-length commercial arrangements. This is like blood flow being diverted to support a family member rather than circulating efficiently through the main system.
-
Concentration Risk: The director (Mr Harvey Louis Alexander) owns more than 75% of shares and is the sole employee. The company's fortunes are entirely tied to one individual.
-
Declining Debtors: Trade debtors fell from £9,135 to £4,944, and group undertakings amounts owed dropped from £79,500 to nil. While the group undertakings clearing is positive, the overall decline in debtors alongside strong profits warrants examination – is revenue being recognised appropriately?
-
Historical Volatility: The dramatic swing from negative to positive net assets raises questions about what drove the recovery. The 2020 accounts still showed net assets of £-51,062, yet by 2023 they had reached £386,557. This represents a swing of over £437,000 in approximately 2-3 years.
Understanding the Business Model
As a holding company (SIC 64209), SIXIS GROUP LIMITED derives value from its subsidiary investments. The £359,208 in subsidiary investments is the primary asset. The company's health is therefore intrinsically linked to the performance of these subsidiaries. The profit generated likely comes from: - Management charges to subsidiaries - Dividends from subsidiaries - Consultancy services (noted in the accounts)
4. Recommendations
Immediate Actions
-
Address Going Concern Dependency: The explicit statement of dependency on director support is concerning. Develop a formal financial plan demonstrating the company can meet day-to-day liabilities without director support. Consider: - Establishing an overdraft facility - Building cash reserves to cover 3-6 months of operating costs - Formalising any director loan arrangements with proper terms
-
Formalise Related-Party Arrangements: The £60,945 interest-free loan to a connected company should be: - Documented with a formal loan agreement - Assessed for recoverability - Considered for market-rate interest terms - Reviewed for whether this represents the best use of company resources
-
Monitor Director Loan: While the director's loan was repaid after year end (£56,784), the fact that such significant amounts flow between the company and its owner-director creates governance concerns. Establish clear policies on inter-company transactions.
Medium-Term Strategic Actions
-
Diversify Revenue Sources: As a holding company with one employee, revenue concentration is high. Consider whether the current structure is optimal or whether activities should be consolidated or expanded.
-
Strengthen Governance: With a single director controlling 75%+ of shares, consider: - Appointing a non-executive director for oversight - Documenting all related-party transactions formally - Establishing a clear dividend policy
-
Review Subsidiary Performance: Given that £359,208 is invested in subsidiaries (63% of total assets), regular monitoring of subsidiary health is essential. The holding company's value is only as strong as its underlying investments.
-
Build Cash Reserves Further: While £89,645 is healthy, consider building reserves to at least 6 months of operating costs to reduce the going concern dependency.
Long-Term Considerations
-
Plan for Succession: The company is entirely dependent on one individual. Consider what happens if the director becomes incapacitated or wishes to exit.
-
Consider Audit: While the company qualifies for audit exemption, obtaining an audit would provide additional credibility to the financial statements, particularly given the dramatic turnaround from insolvency.
-
Review Capital Structure: With only £1 in share capital, the entire equity is held in the profit and loss reserve. Consider whether a capitalisation issue or restructuring might provide a more robust capital structure.
Summary Assessment
| Category | Rating | Notes |
|---|---|---|
| Profitability | A | Strong and consistent profits |
| Liquidity | A | Excellent current ratio and growing cash |
| Solvency | B+ | Positive net assets, but going concern dependency |
| Governance | C | Single director, related-party concerns |
| Stability | B | Dramatic recovery, but historical volatility |
| Overall | B+ | Recovered patient with ongoing monitoring needs |